Soleus Capital Management, L.P. Delcath Systems, Inc. Transaction History
Soleus Capital Management, L.P.
- $1.64 Billion
- Q3 2025
A detailed history of Soleus Capital Management, L.P. transactions in Delcath Systems, Inc. stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 10,000 shares of DCTH stock, worth $89,300. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,000
Previous 25,000
60.0%
Holding current value
$89,300
Previous $340,000
68.53%
% of portfolio
0.01%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding DCTH
# of Institutions
129Shares Held
13.1MCall Options Held
133KPut Options Held
159K-
Vanguard Group Inc Valley Forge, PA1.66MShares$14.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA688KShares$6.14 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT666KShares$5.95 Million0.29% of portfolio
-
State Street Corp Boston, MA621KShares$5.55 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA570KShares$5.09 Million0.97% of portfolio
About DELCATH SYSTEMS, INC.
- Ticker DCTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,597,680
- Market Cap $76.8M
- Description
- Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...